Intracoastal Capital LLC Acquires 9.99% Passive Stake in Artelo Biosciences, Inc. (ARTL)

On April 3, 2026, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G reporting a new 9.99% stake in Artelo Biosciences, Inc. (ARTL). The reporting persons beneficially own 81,701 shares of common stock, which includes 81,000 shares held directly and 701 shares issuable upon the exercise of a warrant. The filing notes that the group actually holds additional warrants for 5,256 and 173,914 shares, but these cannot be exercised due to beneficial ownership blocker provisions that limit their total ownership to 9.99% and 4.99% respectively. Without these contractual blockers, the reporting persons would be deemed to own 260,871 shares. The event triggering this filing occurred on March 30, 2026. The investment is described as passive, with no intent to influence or change the control of the issuer. This filing marks a significant increase from a previous position of zero shares.